Syncom Formulations (India) Ltd
NSE:SYNCOMF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mirada PLC
LSE:MIRA
|
UK |
Syncom Formulations (India) Ltd
Total Receivables
Syncom Formulations (India) Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Syncom Formulations (India) Ltd
NSE:SYNCOMF
|
Total Receivables
₹1.3B
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Receivables
₹97.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Total Receivables
₹69.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Receivables
₹154.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Total Receivables
₹63.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Receivables
₹21.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
Syncom Formulations (India) Ltd
Glance View
Syncom Formulation India Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company is headquartered in Indore, Madhya Pradesh. The firm manufactures and markets more than 300 pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquid orals, liquid vials and ampoule injections and dry vial injections, dry syrups, ointments and inhalers. Its segments include Pharmaceuticals Drugs & Formulations, Trading of Commodities and Renting of property. Its product categories include tablets, capsules, ointments, injections, liquid-oral and packaging variants. The company offers various products, including generics, alpha adrenoceptor agonist, analgesic, antipyretic, anti-inflammatory, anti-ulcer agents, antibiotic, antidepressant, antiviral, cephelo sporins, cortico steroid, estrogen, cough suppressant and sedative anticonvulsant, among others. The firm operates in more than 15 countries across the world.
See Also
What is Syncom Formulations (India) Ltd's Total Receivables?
Total Receivables
1.3B
INR
Based on the financial report for Mar 31, 2025, Syncom Formulations (India) Ltd's Total Receivables amounts to 1.3B INR.
What is Syncom Formulations (India) Ltd's Total Receivables growth rate?
Total Receivables CAGR 3Y
24%
Over the last year, the Total Receivables growth was 13%. The average annual Total Receivables growth rates for Syncom Formulations (India) Ltd have been 24% over the past three years .
